Silence Therapeutics plc (SLN)

NASDAQ: SLN · Real-Time Price · USD

14.59

-0.20 (-1.35%)

At close: Sep 4, 2026, 4:00 PM EDT

13.21

-1.38 (-9.46%)

After-hours: Sep 4, 2026, 7:53 PM EDT

Silence Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	878	287	325	672	547	715
Market Cap Growth	289.89%	-11.59%	-51.64%	22.71%	-23.44%	17.04%
Enterprise Value	807	185	152	600	448	612
Last Close Price	14.59	6.08	6.88	17.37	15.25	23.89

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	1428.38	513.74	7.51	21.23	25.28	42.53
PB Ratio	17.92	4.61	2.42	30.54	20.58	61.93
P/TBV Ratio	31.48	5.59	2.61	57.66	33.06	580.25
P/FCF Ratio	-	-	-	-	-	96.09
P/OCF Ratio	-	-	-	-	-	77.58

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	1311.40	331.26	3.52	18.97	20.67	36.40
EV/FCF Ratio	-	-	-	-	-	82.24

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.00	0.00	0.00	0.02	0.02	0.02
Debt / FCF Ratio	-	-	-	-	-	0.03
Net Debt / Equity Ratio	-1.87	-1.36	-1.10	-3.11	-3.20	-8.61
Net Debt / EBITDA Ratio	1.13	1.04	3.01	1.32	1.68	1.61
Net Debt / FCF Ratio	1.70	1.36	2.17	1.38	1.49	-13.36
Asset Turnover	0.01	0.00	0.27	0.25	0.18	0.14
Quick Ratio	6.40	8.06	10.36	4.15	4.03	5.41
Current Ratio	7.42	8.72	11.14	4.62	4.41	5.69
Return on Equity (ROE)	-90.41%	-90.27%	-58.08%	-223.22%	-273.06%	-448.22%
Return on Assets (ROA)	-29.65%	-30.79%	-19.24%	-26.32%	-26.09%	-31.44%
Return on Capital Employed (ROCE)	-68.80%	-69.80%	-26.70%	-54.00%	-49.70%	-56.50%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-6.82%	-30.86%	-13.95%	-8.07%	-9.20%	-7.46%
FCF Yield	-4.81%	-21.70%	-20.89%	-7.37%	-10.45%	1.04%
Buyback Yield / Dilution	-0.09%	-2.12%	-24.69%	-15.21%	-8.58%	-8.78%

SEC Filings: 10-K · 10-Q